BiomEdit: Over $20 Million Raised For Animal Health Biotechnology Platform
By Amit Chowdhry ● Jul 17, 2025
BiomEdit, an innovative animal health biotechnology company, has achieved a significant milestone with its lead candidate, BE-101, which is designed to prevent mortality from necrotic enteritis (NE) in broiler chickens. The product is now in the final phase of the USDA's conditional licensure process, with a goal of commercialization by 2026. The company also recently closed an oversubscribed Series B financing round, raising approximately $18.4 million, led by Anterra Capital with participation from Nutreco and others.